MedMira, Inc. : MedMira CEO Invited to Speak on Innovation and Technology at the United Nations Conference on Trade and Development
04/17/2012| 10:10am US/Eastern
Recommend:
Halifax, Nova Scotia, April 17, 2012 - MedMira Inc.,
(MedMira) (TSXV: MIR), a developer of rapid diagnostic
technology and solutions, announced today that Company
co-founder and CEO, Hermes Chan, will be speaking at the
Innovation and Technology Day (ITD) in Doha, Qatar on April
24, 2012. ITD, an open forum for technology pioneers,
entrepreneurs, policy makers, and experts, designed to
facilitate the dialogue and action on key issues related to
innovation, technology and development, is a joint initiative
of the United Nations Conference on Trade and Development and
the Qatar Foundation.
Mr. Chan will take the stage to speak about the inspiration
behind MedMira and his experiences in creating and
commercializing Company's patented rapid diagnostics
technology platform and diagnostic applications as well as
the impact of these innovations on both healthcare and
economic growth in developing countries. The audience
will be composed of members of Diplomatic Delegations and
Government officials from many countries as well as
individuals from the network of universities and research
centers of the Qatar Foundation.
"It is a privilege to be invited to speak at UNCTAD XIII
about innovation, something which I am very passionate about
and which is at the heart of everything we have done and
continue to accomplish at MedMira," said Hermes Chan, CEO,
MedMira. "Sharing the MedMira vision in this world
class international forum is a great honor and an exciting
opportunity to build key relationships with organizations
such as UNCTAD, the Qatar Foundation, and other agencies
working to further economic sustainability in developing
countries through innovation and technology."
ITD is part of the thirteenth session of the United Nations
Conference on Trade and Development (UNCTAD XIII) taking
place April 21-26, 2012 in Doha, Qatar. Within the
United Nations system, UNCTAD is the focal point for the
integrated treatment of trade and development and the
interrelated issues in the areas of finance, technology,
investment, and sustainable development. To learn more
visit www.innotechday.org.
About MedMira
MedMira is a leading developer and manufacturer of
flow-through rapid diagnostics and technologies. The
company's tests provide hospitals, labs, clinics and
individuals with reliable, rapid diagnosis for diseases such
as HIV and hepatitis C in just three minutes. The company's
tests are sold under the Reveal®, Multiplo™ and Miriad brands
in global markets. MedMira's rapid flow-through HIV test is
the only one in the world to achieve regulatory approvals in
Canada, the United States, China and the European Union.
MedMira's corporate offices and manufacturing facilities are
located in Halifax, Nova Scotia, Canada. For more information
visit MedMira's website at www.medmira.com.
This news release contains forward-looking statements,
which involve risk and uncertainties and reflect the
Company's current expectation regarding future events
including statements regarding possible future growth and new
business opportunities. Actual events could materially
differ from those projected herein and depend on a number of
factors including, but not limited to, changing market
conditions, successful and timely completion of clinical
studies, uncertainties related to the regulatory approval
process, establishment of corporate alliances and other risks
detailed from time to time in the company quarterly
filings.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
MedMira Contact:
Andrea Young, Corporate Communications
Tel: 902-450-1588
Email: ayoung@medmira.com
distributed by
|
|
Recommend :
